Australian digital health company ResApp Health Limited has received approval for the latest version of the world’s first smartphone-based diagnostic test for respiratory disease for both adults and children. This extends existing approval and adds the ability to test adults for lower respiratory tract disease, pneumonia, asthma exacerbation and chronic obstructive pulmonary disease exacerbation. This certification also allows the sale of this app throughout the European Economic Area. | http://bit.ly/33boyLp
"Great ideas, research and innovation can come from anyone – so often the best ideas do not have a voice. IdeaSpies provides a platform for people to share ideas that create a better world"
IdeaSpies
Jonathan Chrimes